134 related articles for article (PubMed ID: 946592)
1. Lymphosarcoma. A comparison of extended to conservative chemotherapy.
Kaufman JH; Ezdinli E; Aungst CW; Stutzman L
Cancer; 1976 Mar; 37(3):1283-92. PubMed ID: 946592
[TBL] [Abstract][Full Text] [Related]
2. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
[TBL] [Abstract][Full Text] [Related]
3. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
4. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
5. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Durant JR; Loeb V; Dorfman R; Chan YK
Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
[TBL] [Abstract][Full Text] [Related]
6. A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphoma.
Benjamin RS; Wiernik PH; O'Connell MJ; Chang P; Sutherland JC
Cancer; 1976 Nov; 38(5):1896-902. PubMed ID: 1036467
[TBL] [Abstract][Full Text] [Related]
7. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
Durant JR; Gams RA; Bartolucci AA; Dorfman RF
Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
[TBL] [Abstract][Full Text] [Related]
8. [Polychemotherapy using prednisone, cyclophosphamide, and vincristine in stage IV lymphosarcoma].
Focan C; Hugues J
Acta Clin Belg; 1973; 28(5):287-97. PubMed ID: 4801315
[No Abstract] [Full Text] [Related]
9. Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survival.
Icli F; Ezdinli EZ; Costello W; Berard CW; Bennett JM; Carbone PP
Cancer; 1978 Oct; 42(4):1936-42. PubMed ID: 581359
[TBL] [Abstract][Full Text] [Related]
10. Carmustine, vincristine, and prednisone in the treatment of canine lymphosarcoma.
Ricci Lucas SR; Pereira Coelho BM; Marquezi ML; Franchini ML; Miyashiro SI; De Benedetto Pozzi DH
J Am Anim Hosp Assoc; 2004; 40(4):292-9. PubMed ID: 15238559
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma.
Lowenbraun S; DeVita VT; Serpick AA
Cancer; 1970 May; 25(5):1018-25. PubMed ID: 4910254
[No Abstract] [Full Text] [Related]
12. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
[TBL] [Abstract][Full Text] [Related]
13. [Progress in combination chemotherapy of malignant lymphomas (author's transl)].
Senn HJ
Schweiz Rundsch Med Prax; 1973 Dec; 62(51):1589-94. PubMed ID: 4771027
[No Abstract] [Full Text] [Related]
14. Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors.
Steward WP; Crowther D; McWilliam LJ; Jones JM; Deakin DP; Todd ID; Blackledge G; Wagstaff J; Scarffe JH; Harris M
Cancer; 1988 Feb; 61(3):441-7. PubMed ID: 3338014
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
[TBL] [Abstract][Full Text] [Related]
16. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Fisher RI; Dana BW; LeBlanc M; Kjeldsberg C; Forman JD; Unger JM; Balcerzak SP; Gaynor ER; Roy V; Miller T
J Clin Oncol; 2000 May; 18(10):2010-6. PubMed ID: 10811664
[TBL] [Abstract][Full Text] [Related]
18. Combination versus successive single agent chemotherapy in lymphocytic lymphoma.
Kennedy BJ; Bloomfield CD; Kiang DT; Vosika G; Peterson BA; Theologides A
Cancer; 1978 Jan; 41(1):23-8. PubMed ID: 580070
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
Bennett JM; Bakemeier RF; Carbone PP; Ezdinli E; Lenhard RE
Cancer Treat Rep; 1976 Jun; 60(6):739-45. PubMed ID: 60176
[No Abstract] [Full Text] [Related]
20. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
